Aorta phenotype | Non-dilated aorta 168 (20.2%) | Dilated aorta 663 (79.8%) | ||||
Aortic root 77 (45.8%) | Ascending aorta 91 (54.2%) | p Value | Aortic root 122 (18.4%) | Ascending aorta 541 (81.6%) | p Value | |
Univariate analysis Demographics and clinical data | ||||||
Age, years | 42.1±17.4 | 49.2±14.5 | 0.066 | 41.5±16.9 | 49.2±16.6 | 0.0001 |
Male, n (%) | 58 (75.3) | 61 (67.0) | 0.307 | 106 (86.9) | 363 (67.1) | 0.0001 |
Smoking, n (%) | 15 (19.4) | 28 (31.0) | 0.139 | 32 (26.4) | 163 (30.1) | 0.502 |
Hypertension, n (%) | 15 (19.4) | 27 (27.2) | 0.099 | 32 (26.4) | 185 (34.2) | 0.009 |
Diabetes mellitus, n (%) | 3 (4.8) | 10 (11.1) | 0.143 | 4 (3.3) | 27 (5.2) | 0.511 |
Dyslipidaemia, n (%) | 13 (17.3) | 22 (24.1) | 0.332 | 20 (16.5) | 130 (24.0) | 0.074 |
Valve morphotype | ||||||
0.006 | 0.001 | |||||
BAV-RL, n (%) | 54 (77.1) | 45 (49.4) | 101 (83.0) | 385 (71.1) | ||
BAV-RN, n (%) | 13 (18.6) | 36 (40.1) | 10 (8.2) | 135 (25.1) | ||
BAV-LN, n (%) | 3 (4.3) | 2 (2.2) | 7 (5.7) | 12 (2.2) | ||
Valve abnormality and function | ||||||
Raphe, n (%) | 57 (74.0) | 64 (70.3) | 0.486 | 92 (75.4) | 429 (79.3) | 0.362 |
Sigmoid prolapse, n (%) | 7 (9.1) | 9 (9.9) | 0.999 | 23 (18.9) | 71 (13.1) | 0.112 |
Non-significant valve dysfunction, n (%) | 58 (75.3) | 58 (63.7) | 0.105 | 65 (53.3) | 266 (49.2) | 0.001 |
AS dominant, n (%) | 6 (7.8) | 23 (25.3) | 7 (5.7) | 148 (27.4) | ||
AR dominant, n (%) | 13 (16.9) | 10 (11.0) | 50 (41.0) | 127 (23.5) |